Ganji Purnachandra Nagaraju, MSc, PhD, DSc



Dr. Nagaraju has contributed to discoveries in the field of cancer biology and molecular biology and is internationally recognized as a leader in this field by the Elsevier Science publishers.

Titles and Roles

Instructor, Department of Hematology and Medical Oncology
Emory University School of Medicine
Research Program
Discovery and Developmental Therapeutics


Ganji Purnachandra Nagaraju, MSc, PhD, DSc, is an Instructor in the Department of Hematology and Medical Oncology at Emory University School of Medicine.

Dr. Nagaraju is a member of the Discovery and Developmental Therapeutics research program at Winship Cancer Institute. He also holds memberships with the Association of Scientists of Indian Origin in America, the Society for Integrative and Comparative Biology, the Science Advisory Board, The RNA Society and the American Association of Cancer Research.


Dr. Nagaraju obtained his MSc and his PhD, both in biotechnology, from Sri Venkateswara University in Tirupati, Andhra Pradesh, India. He received his DSc from Berhampur University in Brahmapur, Odisha, India.


Dr. Nagaraju's research is on translational projects related to gastrointestinal malignancies, specifically pancreatic and colorectal cancer, to bring observations derived from in vitro models of cancer cell growth to the translational level. He closely collaborates with clinicians in studies that target the HSP90, SPARC and DNMT-1 cell signaling pathways in pancreatic as well as colorectal cancer cells.


Dr. Nagaraju has published over 70 research papers in several prestigious peer-reviewed journals and has presented more than 50 abstracts at various national and international conferences. He serves as an editorial board member of several internationally recognized academic journals.

Dr, Nagaraju is author and editor of several published books including "Role of Tyrosine Kinases in Gastrointestinal Malignancies", "Role of Transcription Factors in Gastrointestinal Malignancies" and "Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy."

  • PublicationsPublication Date


Dr. Nagaraju has received the following awards and honors:

  • Distinguished Young Scientist in Gastrointestinal Malignancies, RULA Awards, 2019
  • Junior Scientist award by the ASIOA, 2012
  • Emory Research Staff Award, 2012
  • Emory Outstanding oral presentation award – Postdoc symposium at Emory University, 2012
  • Recognized as a leader in Endocrinology field by the Elsevier Science publishers, 2007
  • Postdoctoral Fellow Award from NSC, Taiwan Govt, ROC, 2004
  • Senior Research Fellow Award from ICAR, New Delhi, 1999

Additional Websites

Cascade Link   TOP